MAIN-THEME 2_son - PLANNING FOR THE NEXT SEVEN YEARS GBA...

Info iconThis preview shows pages 1–4. Sign up to view the full content.

View Full Document Right Arrow Icon
PLANNING FOR THE NEXT SEVEN YEARS GBA CONSULTANTS Expert Analysis for the Pharmaceutical Industry Pharmaceutical Industry Analyst INTRODUCTION
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
The pharmaceutical industry remains one of the most profitable industries in the nation. In order to maintain this status, the pharmaceutical industry relies heavily on the vitality of its research and development investments, as well as the importance of horizontal mergers within the industry. This report designed for GBA consultants examines competition issues in the United States pharmaceutical industry. The objective of this report is to analyze two competitive issues that may affect the pharmaceutical industry. It will begin with the evolution of the industry and its current market share. The remaining portion of the report will concentrate on two current issues occurring within the industry. The first issue concentrates on the importance of investing in research and development, and funding provided by biotech companies. The second issue concentrates on how continued mergers among major industries are reshaping the industry as a whole. The report ends with a summary, which concludes all issues with their impacts. DESCRIPTION OF COMPETITION IN THE PHARMACEUTICAL INDUSTRY 2
Background image of page 2
Large firms set up the pharmaceutical industry’s competitive strategies in U.S. The U.S. pharmaceutical industry is a highly diversified industry, producing a variety of health care products. A. Major Competitors in U.S. Market Few large firms dominate the U.S. pharmaceutical industry. Structurally, the pharmaceutical industry exhibits the form of an oligopoly. Although Merck & Co. Inc. is the world's largest pharmaceutical company, with annual sales of about $5 billion, U.S. pharmaceutical market is lead by Pfizer Inc. With the help of two top ten products, Lipitor and Zoloft, Pfizer holds 10.1% percent of the U.S. pharmaceutical market. Pfizer’s net dollar volume was $18,532 millions for the first half of year 2002. The second biggest company in U.S. pharmaceutical industry is GlaxoSmithKline with dollar volume of $16,659 millions and 9.1% percent U.S. pharmaceutical market share. They are followed by Merck. Merck is the third largest pharmaceutical company in U.S pharmacy industry with volume of $12,905 millions and 7.0% percent market share. Top 10 manufacturers represent 53% percent of the U.S. pharmaceutical industry. The information, which was given above, was taken from IMS Health, June 2002. For the complete list please see the appendixes A.
Background image of page 3

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Image of page 4
This is the end of the preview. Sign up to access the rest of the document.

This note was uploaded on 03/23/2010 for the course BA MBA 534 taught by Professor Alikutan during the Spring '05 term at Southwestern Illinois.

Page1 / 7

MAIN-THEME 2_son - PLANNING FOR THE NEXT SEVEN YEARS GBA...

This preview shows document pages 1 - 4. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online